Get notified when TVRD files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TVRD Tvardi Therapeutics, Inc. 8-K

Tvardi increases ATM offering capacity by $9.7M after selling $11M in prior year

Filed July 17, 2026 · Period ending July 17, 2026 · ~1 min read

Key Changes

  • medium

    Filed prospectus supplement to increase at-the-market offering capacity by $9.7M in common stock, beyond the $11.0M in gross proceeds already raised in the prior twelve months.

    Item 8.01 — Other Events verify on EDGAR →
  • medium

    Sold 3,110,769 shares for approximately $11.0M in gross proceeds during the twelve months ending July 17, 2026, under the original ATM program.

    Item 8.01 — Other Events verify on EDGAR →
  • medium

    Public float calculated at $62.2M (12,441,789 non-affiliate shares at $5.00 per share as of July 8, 2026), allowing total offerings up to approximately $20.7M under baby shelf rules.

    Item 8.01 — Other Events verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (TRV 10-Q) is open in full — no account needed.

Partner

Trade TVRD commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Source-verified from EDGAR · Narrative written by AI · Jul 19, 2026 · How we verify